-
Mashup Score: 1Data-Driven Insights | 20 Years of FDA Leadership in Novel Cancer Drug Approvals - Friends of Cancer Research - 8 hour(s) ago
Authors: Bhaavna Yalavarthi1 and Grace Collins2 In 2011, Friends published a study in Health Affairs that challenged the prevailing narrative of the time, which suggested that the U.S. Food and Drug Administration (FDA) was slower and less efficient than other regulatory authorities, such as the European Medicines Agency (EMA). This study provided evidence to the…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet
New Study: @US_FDA leads the world in approving novel #oncology drugs, reviewing almost twice as fast as the EMA and ensuring faster #patientaccess to lifesaving treatments. Read our latest blog post for the full findings: https://t.co/D4dBC2Qavi https://t.co/Rj8aGV1dfn